Mechanisms underlying pre‐ and postjunctional effects of neuropeptide Y in sympathetic vascular control
- 1 February 1986
- journal article
- Published by Wiley in Acta Physiologica Scandinavica
- Vol. 126 (2), 239-249
- https://doi.org/10.1111/j.1748-1716.1986.tb07811.x
Abstract
The effects of porcine neuropeptide Y (NPY) regarding sympathetic vascular control were studied in vitro on isolated rat blood vessels. The 10 -9 M NPY enhanced (about two-fold) the contractile responses to transmural nerve stimulation (TNS), noradrenaline (NA) and adrenaline (about two-fold) in the femoral artery. Higher concentrations of NPY (> 10-8 M) caused an adrenoceptor-resistant contraction per se. The TNS-evoked [3H]NA efflux was significantly reduced by NPY in a concentration-dependent manner (threshold 10 -9 M). The calcium antagonist, nifedipine, abolished the contractile effects of NPY and the NPY-induced enhancement of NA contractions but did not influence the prejunctional inhibition of [3H]NA release. Receptor-binding studies showed that the ratio of alpha1- to alpha2-adrenoceptors in the femoral artery was 30:1. The NPY did not cause any detectable change in the number of alpha1- or alpha2-adrenoceptor binding sites or in the affinity of alpha2-binding sites, as revealed by prazosin- and clonidine-binding, respectively. The NPY also inhibited the TNS-evoked [3H]NA release (by 42–86%) in the superior mesenteric and basilar arteries and in femoral and portal veins. The NPY still depressed TNS-evoked [3H]NA secretion from the portal vein in the presence of phentolamine. The NPY caused a clear-cut contraction in the basilar artery, increased the contractile force of spontaneous contractions in the portal vein, while only weak responses were observed in the superior mesenteric artery and femoral vein. The NA-induced contraction was markedly enhanced by NPY in the superior mesenteric artery, only slightly enhanced in the portal vein and uninfluenced in the femoral vein. In conclusion, in all blood vessels tested, NPY depresses the TNS-evoked [3H]NA secretion via a nifedipine-resistant action. Furthermore, NPY exerts a variable, Ca2+-dependent vasoconstrictor effect and enhancement of NA and TNS contractions.Keywords
This publication has 27 references indexed in Scilit:
- Neuropeptide Y and sympathetic control of heart contractility and coronary vascular toneActa Physiologica Scandinavica, 1985
- INTERACTION OF PEPTIDES PRESENT IN PERIVASCULAR NERVES ON THE SMOOTH MUSCLE OF CAT CEREBRAL ARTERIES AND ON THE STIMULATION‐EVOKED EFFLUX OF 3H‐NORADRENALINEJournal of Autonomic Pharmacology, 1984
- Neuropeptide Y (NPY) depresses the secretion of 3H‐noradrenaline and the contractile response evoked by field stimulation, in rat vas deferensActa Physiologica Scandinavica, 1984
- On the Mechanism of Action of Calcium AntagonistsActa Medica Scandinavica, 1984
- Neuropeptide Y: Cerebrovascular innervation an vasomotor effects in the catNeuroscience Letters, 1983
- Neuropeptide Y in vitro selectively increases the number of α2‐adrenergic binding sites in membranes of the medulla oblongata of the ratActa Physiologica Scandinavica, 1983
- Neuropeptide Y (NPY)‐like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic functionActa Physiologica Scandinavica, 1982
- Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to α‐adrenoceptor blockadeActa Physiologica Scandinavica, 1982
- Pre-and postjunctional beta-adrenoceptor mediated effects on transmitter release and effector response in the isolated rat portal veinActa Physiologica Scandinavica, 1980
- Direct biochemical demonstration of two types of α-adrenoreceptor in rat brainNature, 1978